Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-Sc1 in pregnancy.

T Kaye1, E M Williams, S F Garner

  • 1South London Blood Transfusion Centre, England.

Transfusion
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptions of black women with systemic lupus erythematosus on continuity in care coordination: a mixed methods pilot study conducted in the USA.

BMC musculoskeletal disorders·2026
Same author

Utility, feasibility, and socio-demographic considerations in the diagnosis of bacterial RTI's by GC-IMS breath analysis.

iScience·2024
Same author

Identifying Risk Factors for Anthracycline Chemotherapy-induced Phlebitis in Women with Breast Cancer: An Observational Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Printed titanium implants in UK craniomaxillofacial surgery. Part II: perceived performance (outcomes, logistics, and costs).

The British journal of oral & maxillofacial surgery·2020
Same author

Printed titanium implants in UK craniomaxillofacial surgery. Part I: access to digital planning and perceived scope for use in common procedures.

The British journal of oral & maxillofacial surgery·2020
Same author

Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study.

Lupus·2019
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
Same journal

AABB survey on directed blood donation practices.

Transfusion·2026
Same journal

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
See all related articles

This study tracked anti-Sc1 antibodies during pregnancy. Despite a positive direct antiglobulin test at birth, the infant showed no signs of hemolytic disease, indicating a favorable outcome.

Area of Science:

  • Immunology
  • Maternal-Fetal Medicine

Background:

  • Detection of anti-Sc1 antibodies during pregnancy can pose a risk for hemolytic disease of the fetus and newborn (HDFN).
  • Monitoring antibody levels and subclass is crucial for assessing potential fetal risk.

Observation:

  • Anti-Sc1 antibodies, IgG3 subclass, were detected early in gestation.
  • Antibody-dependent cellular cytotoxicity (ADCC) assay showed low initial fetal lysis (7%), suggesting low risk.
  • Direct antiglobulin test was positive at birth, but the infant had normal hemoglobin and required no transfusion.

Findings:

  • The anti-Sc1 antibody titer and IgG3 subclass remained stable throughout pregnancy.
  • Postnatal ADCC assay showed increased lysis (44%), correlating with a higher antibody titer.
  • The infant did not develop HDFN despite a positive direct antiglobulin test.

Related Experiment Videos

Implications:

  • This case highlights the potential for a favorable fetal outcome even with detectable anti-Sc1 antibodies and a positive direct antiglobulin test.
  • Antibody-dependent cellular cytotoxicity (ADCC) assay may provide valuable information in predicting fetal risk.
  • Further research is needed to fully understand the predictive value of ADCC assays in managing Rh-sensitized pregnancies.